Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Congenital syphilis in a preterm newborn with gastrointestinal disorders and postnatal growth restriction.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101510759 Publication Model: Electronic Cited Medium: Internet ISSN: 1824-7288 (Electronic) Linking ISSN: 17208424 NLM ISO Abbreviation: Ital J Pediatr Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : BioMed Central
    • الموضوع:
    • نبذة مختصرة :
      Background: Congenital syphilis (CS) depends on the placental transmission of Treponema pallidum (TP) spirochetes from an infected mother to fetus during pregnancy. It shows a wide clinical variability with cutaneous and visceral manifestations, including stillbirths, neonatal death, and asymptomatic cases. Preterm infants with CS may have more severe features of disease than the term ones, due to the combined pathogenic effect of both CS and prematurity.
      Case Presentation: We report on a female preterm (32 +6  weeks of gestation) newborn showing most of the typical CS manifestations, in addition to gastrointestinal disorders including feeding difficulties, colon stenosis and malabsorption leading to postnatal growth restriction. The mother resulted positive at the syphilis screening test of the first trimester of pregnancy, but she did not undergo any treatment. At birth, our newborn was VDRL positive (antibody titer four times higher compared to the mother), and she was treated with intravenous benzathine benzylpenicillin G for 10 days (50,000 IU/Kg three times per day). Poor tolerance to enteral nutrition (abdominal distension, increased biliary type gastric secretions) was observed. A barium enema X-Ray identified a colon stenosis within the descending tract. However, the poor general conditions due to a concurrent fungal sepsis did not allow to perform any surgical procedure, and a conservative approach with total parenteral nutrition was started. The following evolution was marked by difficulties in enteral feeding including refusal of food and vomiting, to which also contributed the neurological abnormalities related to a perinatal asphyxia, and the affective deprivation for the physical absence of the mother during hospitalization. At 5 months of age, after the introduction of an amino acid-based formula (Neocate LCP Nutricia ®), an improvement of enteral feeding was observed, with no further and significantly decreased episodes of abdominal distension and vomiting respectively, and regular stool emission. A psychological support offered to the family allowed a more stable bond between the mother and her baby, thus providing a significant additional benefit to food tolerance and growth. She was discharged at 5 months of age, and included in a multidisciplinary follow-up. She at present shows global growth delay, and normal development apart from mildly increased tone of lower limbs.
      Conclusions: Our report highlights less common clinical CS manifestations like gastrointestinal disorders including feeding difficulties, colon stenosis and malabsorption leading to postnatal growth delay. Moreover, it underlines how prematurity may worsen the clinical evolution of such congenital infection, due to the additional pathogenic effect of possible associated diseases and/or conditions like sepsis, hypoxic/ischemic injury, or use of drugs. CS may be observed also in high-income countries, with high rates of antenatal screening and availability of prenatal treatment. A multidisciplinary network must be guaranteed to the affected subjects, to ensure adequate care and improve the quality of life for patients and their families.
      (© 2022. The Author(s).)
    • References:
      Minerva Pediatr. 2012 Feb;64(1):59-64. (PMID: 22350046)
      Ital J Pediatr. 2022 Jul 29;48(1):133. (PMID: 35906671)
      Ital J Pediatr. 2021 Jun 16;47(1):138. (PMID: 34134742)
      Ital J Pediatr. 2021 Apr 19;47(1):94. (PMID: 33874990)
      Clin Gastroenterol Hepatol. 2005 Sep;3(9):875-85. (PMID: 16234025)
      Am J Med Genet A. 2012 Jun;158A(6):1427-33. (PMID: 22581785)
      J Pediatr Surg. 1988 Sep;23(9):810-3. (PMID: 3183893)
      Ital J Pediatr. 2021 Nov 14;47(1):226. (PMID: 34775993)
      S Afr Med J. 1988 Nov 5;74(9):464-5. (PMID: 3187834)
      Birth. 2009 Jun;36(2):97-109. (PMID: 19489802)
      Ital J Pediatr. 2020 Oct 15;46(1):154. (PMID: 33059727)
      Ital J Pediatr. 2020 May 24;46(1):72. (PMID: 32448340)
      Ital J Pediatr. 2022 Jul 29;48(1):132. (PMID: 35906647)
      Prenat Diagn. 2020 Dec;40(13):1703-1714. (PMID: 32362058)
      Ital J Pediatr. 2021 Jul 1;47(1):147. (PMID: 34210338)
      New Microbiol. 2013 Jan;36(1):97-101. (PMID: 23435823)
      J Clin Microbiol. 2021 Sep 20;59(10):e0010021. (PMID: 33980644)
      Lancet Infect Dis. 2020 Jul;20(7):e173-e179. (PMID: 32502432)
      Pediatr Surg Int. 1999 Jul;15(5-6):391-3. (PMID: 10415295)
      Ital J Pediatr. 2021 Dec 18;47(1):239. (PMID: 34922600)
      Johns Hopkins Med J. 1971 Aug;129(2):63-82. (PMID: 5567603)
      Ital J Pediatr. 2022 Feb 3;48(1):19. (PMID: 35115028)
      Ital J Pediatr. 2021 Sep 28;47(1):196. (PMID: 34583755)
      Neoreviews. 2021 Sep;22(9):e585-e599. (PMID: 34470760)
      Ital J Pediatr. 2022 May 4;48(1):65. (PMID: 35509048)
      Ital J Pediatr. 2020 Sep 24;46(1):140. (PMID: 32972427)
      Ital J Pediatr. 2019 Nov 29;45(1):152. (PMID: 31783883)
      Ital J Pediatr. 2022 Mar 4;48(1):38. (PMID: 35246213)
      Medicine (Baltimore). 2020 Oct 02;99(40):e22321. (PMID: 33019408)
      Ital J Pediatr. 2022 Sep 8;48(1):170. (PMID: 36076277)
      Nutr Clin Pract. 2020 Apr;35(2):273-281. (PMID: 30742336)
      Clin Case Rep. 2018 Jan 13;6(2):399-401. (PMID: 29445485)
      Ital J Pediatr. 2022 Aug 13;48(1):145. (PMID: 35964051)
      Infez Med. 2013 Jun;21(2):142-5. (PMID: 23774980)
      Acta Med Port. 1979 Sep-Oct;1(5):569-75. (PMID: 551705)
      Ital J Pediatr. 2022 Aug 4;48(1):140. (PMID: 35927685)
      Semin Perinatol. 2018 Apr;42(3):176-184. (PMID: 29627075)
      Eur J Pediatr. 2022 Nov 14;:. (PMID: 36376519)
      Ital J Pediatr. 2020 Sep 18;46(1):136. (PMID: 32948218)
      Clin Dysmorphol. 2020 Jul;29(3):141-143. (PMID: 32433043)
      Ital J Pediatr. 2015 Apr 01;41:27. (PMID: 25887621)
      Am J Perinatol. 2016 Sep;33(11):1099-103. (PMID: 27603544)
    • Contributed Indexing:
      Keywords: Case report; Congenital syphilis (CS); Gastrointestinal symptoms; Growth delay; Prematurity
    • الموضوع:
      Date Created: 20221229 Date Completed: 20230102 Latest Revision: 20230103
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC9801585
    • الرقم المعرف:
      10.1186/s13052-022-01404-5
    • الرقم المعرف:
      36581899